Cyren (NASDAQ:CYRN) Coverage Initiated by Analysts at started coverage on shares of Cyren (NASDAQ:CYRNGet Rating) in a research report sent to investors on Monday morning. The brokerage issued a hold rating on the technology company’s stock.

Cyren Trading Down 4.3 %

Shares of NASDAQ CYRN opened at $0.89 on Monday. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 2.30. The company has a market cap of $6.92 million, a PE ratio of -0.17 and a beta of 0.62. The company has a 50-day moving average of $1.07 and a two-hundred day moving average of $1.57. Cyren has a 1-year low of $0.86 and a 1-year high of $13.87.

Institutional Investors Weigh In On Cyren

Large investors have recently bought and sold shares of the company. Virtu Financial LLC acquired a new position in shares of Cyren in the first quarter valued at approximately $59,000. Millennium Management LLC bought a new stake in Cyren during the second quarter worth $48,000. Jane Street Group LLC bought a new stake in Cyren during the first quarter worth $426,000. Finally, Nantahala Capital Management LLC bought a new position in shares of Cyren in the third quarter valued at about $139,000. Institutional investors own 21.47% of the company’s stock.

Cyren Company Profile

(Get Rating)

Cyren Ltd., together with its subsidiaries, provides cloud delivered Software-as-a-Service (SaaS) cybersecurity solutions that protect businesses, their employees, and customers against threats from email, files, and the web. It provides Cyren threat detection services, which include email security engine that offers anti-spam inbound and outbound, IP reputation, and virus outbreak detection services; malware detection engine that is used to protect email applications; Web security engine, which is used by customers to provide URL classification for web browser filtering and safe search capabilities; and threat analysis services to detect advanced cyber threats.

Read More

Receive News & Ratings for Cyren Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyren and related companies with's FREE daily email newsletter.